Deepak Phadke

Person

Olathe, KS, US

People

Patents Grantslast 30 patents

Information Patent Grant
Highly purified pharmaceutical grade tasimelteon
- Patent number 12,049,457
- Issue date Jul 30, 2024
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Highly purified pharmaceutical grade tasimelteon
- Patent number 11,760,740
- Issue date Sep 19, 2023
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Liquid tasimelteon formulations and methods of use thereof
- Patent number 11,759,446
- Issue date Sep 19, 2023
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly purified pharmaceutical grade tasimelteon
- Patent number 11,566,011
- Issue date Jan 31, 2023
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Liquid tasimelteon formulations and methods of use thereof
- Patent number 11,202,770
- Issue date Dec 21, 2021
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly purified pharmaceutical grade tasimelteon
- Patent number 11,203,581
- Issue date Dec 21, 2021
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Iloperidone metabolite for use in the treatment of psychiatric diso...
- Patent number 10,874,659
- Issue date Dec 29, 2020
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly purified pharmaceutical grade tasimelteon
- Patent number 10,829,465
- Issue date Nov 10, 2020
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Highly purified pharmaceutical grade tasimelteon
- Patent number 10,611,744
- Issue date Apr 7, 2020
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...
- Patent number 10,233,142
- Issue date Mar 19, 2019
- Vanda Pharmaceuticals Inc.
- Marlene Michelle Dressman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly purifid pharmaceutical grade tasimelteon
- Patent number 10,071,977
- Issue date Sep 11, 2018
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...
- Patent number 9,850,199
- Issue date Dec 26, 2017
- Vanda Pharmaceuticals, Inc.
- Marlene Michelle Dressman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...
- Patent number 9,617,203
- Issue date Apr 11, 2017
- Vanda Pharmaceuticals Inc.
- Marlene Michelle Dressman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...
- Patent number 9,212,129
- Issue date Dec 15, 2015
- Vanda Pharmaceuticals, Inc.
- Marlene Michelle Dressman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable dosage formulations of imidazolylalkyl-pyridines
- Patent number 8,865,210
- Issue date Oct 21, 2014
- Vanda Pharmaceuticals, Inc.
- Christian N. Lavedan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for piperidinoalkanol compounds
- Patent number 8,129,408
- Issue date Mar 6, 2012
- Aventisub II Inc.
- Thomas T Ortyl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for piperidinoalkanol compounds
- Patent number 6,113,942
- Issue date Sep 5, 2000
- Aventis Pharmaceuticals Inc.
- Thomas T. Ortyl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for piperidinoalkanol compounds
- Patent number 5,932,247
- Issue date Aug 3, 1999
- Hoechst Marion Roussel, Inc.
- Thomas T. Ortyl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions for piperidinalkanol compounds
- Patent number 5,855,912
- Issue date Jan 5, 1999
- Hoechst Marion Roussel, Inc.
- Thomas T. Ortyl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for piperidinoalkanol compounds
- Patent number 5,738,872
- Issue date Apr 14, 1998
- Hoechst Marion Roussel, Inc.
- Thomas T. Ortyl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Superior tasting pharmaceutical composition having porous particles...
- Patent number 5,437,873
- Issue date Aug 1, 1995
- Merrell Dow Pharmaceuticals Inc.
- Deepak S. Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Superior tasting composition having porous particles and the proces...
- Patent number 5,302,396
- Issue date Apr 12, 1994
- Merrell Dow Pharmaceuticals Inc.
- Deepak S. Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sugar-free dry mix cellulose ether compositions as bulk laxatives
- Patent number 5,266,334
- Issue date Nov 30, 1993
- Merrell Dow Pharmaceuticals Inc.
- Deepak S. Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20240336584
- Publication date Oct 10, 2024
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20240325339
- Publication date Oct 3, 2024
- Vanda Pharmaceuticals Inc.
- Gunther P. Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISO...
- Publication number 20240016791
- Publication date Jan 18, 2024
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20230382883
- Publication date Nov 30, 2023
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Liquid Tasimelteon Formulations and Methods of Use Thereof
- Publication number 20230372285
- Publication date Nov 23, 2023
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20230150964
- Publication date May 18, 2023
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20230021493
- Publication date Jan 26, 2023
- Vanda Pharmaceuticals Inc.
- Gunther P. Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ophthalmic Pharmaceutical Compositions
- Publication number 20230026577
- Publication date Jan 26, 2023
- Vanda Pharmaceuticals Inc.
- Udaya KOTREKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20220073482
- Publication date Mar 10, 2022
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Liquid Tasimelteon Formulations and Methods of Use Thereof
- Publication number 20210212980
- Publication date Jul 15, 2021
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Liquid Tasimelteon Formulations and Methods of Use Thereof
- Publication number 20210177799
- Publication date Jun 17, 2021
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20210017143
- Publication date Jan 21, 2021
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISO...
- Publication number 20210015809
- Publication date Jan 21, 2021
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20200397741
- Publication date Dec 24, 2020
- Vanda Pharmaceuticals Inc.
- Gunther P. Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20200190048
- Publication date Jun 18, 2020
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY PURIFID PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20190002423
- Publication date Jan 3, 2019
- Vanda Pharmaceuticals Inc.
- Deepak Phadke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20180243258
- Publication date Aug 30, 2018
- Vanda Pharmaceuticals, Inc.
- Gunther P. Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...
- Publication number 20180099924
- Publication date Apr 12, 2018
- Vanda Pharmaceuticals, Inc.
- Marlene Michelle Dressman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY PURIFID PHARMACEUTICAL GRADE TASIMELTEON
- Publication number 20170190683
- Publication date Jul 6, 2017
- Vanda Pharmaceuticals Inc.
- Deepak PHADKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...
- Publication number 20170174617
- Publication date Jun 22, 2017
- Vanda Pharmaceuticals, Inc.
- Marlene Michelle Dressman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20160354337
- Publication date Dec 8, 2016
- Vanda Pharmaceuticals, Inc.
- Gunther Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...
- Publication number 20160060212
- Publication date Mar 3, 2016
- Vanda Pharmaceuticals, Inc.
- Marlene Michelle Dressman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...
- Publication number 20150148419
- Publication date May 28, 2015
- Vanda Pharmaceuticals, Inc.
- Marlene Michelle Dressman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20150080464
- Publication date Mar 19, 2015
- Vanda Pharmaceuticals, Inc.
- Gunther Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISO...
- Publication number 20150045390
- Publication date Feb 12, 2015
- Vanda Pharmaceuticals, Inc.
- Deepak Phadke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A MELATONIN AGONIST FOR THE TREATMENT OF SLEEP DISORDERS INC...
- Publication number 20120136050
- Publication date May 31, 2012
- VANDA PHARMACEUTICALS INC.
- Mihael H. Polymeropoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALKANOL COMPOUNDS
- Publication number 20100021547
- Publication date Jan 28, 2010
- Aventis Pharmaceuticals Inc.
- Thomas T. ORTYL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT FOR DEPRESSIVE DISORDERS
- Publication number 20090209638
- Publication date Aug 20, 2009
- Gunther Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MELATONIN AGONIST TREATMENT
- Publication number 20090105333
- Publication date Apr 23, 2009
- Gunther Birznieks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE DOSAGE FORMULATIONS OF IMIDAZOLYLALKYL-PYRIDINES
- Publication number 20090011011
- Publication date Jan 8, 2009
- Christian N. Lavedan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Deepak Phadke

Person

Patents Grantslast 30 patents

Highly purified pharmaceutical grade tasimelteon

Highly purified pharmaceutical grade tasimelteon

Liquid tasimelteon formulations and methods of use thereof

Highly purified pharmaceutical grade tasimelteon

Liquid tasimelteon formulations and methods of use thereof

Highly purified pharmaceutical grade tasimelteon

Iloperidone metabolite for use in the treatment of psychiatric diso...

Highly purified pharmaceutical grade tasimelteon

Highly purified pharmaceutical grade tasimelteon

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...

Highly purifid pharmaceutical grade tasimelteon

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopr...

Stable dosage formulations of imidazolylalkyl-pyridines

Pharmaceutical composition for piperidinoalkanol compounds

Pharmaceutical composition for piperidinoalkanol compounds

Pharmaceutical composition for piperidinoalkanol compounds

Pharmaceutical compositions for piperidinalkanol compounds

Pharmaceutical composition for piperidinoalkanol compounds

Superior tasting pharmaceutical composition having porous particles...

Superior tasting composition having porous particles and the proces...

Sugar-free dry mix cellulose ether compositions as bulk laxatives

Patents Applicationslast 30 patents

HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON

MELATONIN AGONIST TREATMENT

ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISO...

HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON

Liquid Tasimelteon Formulations and Methods of Use Thereof

HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON

MELATONIN AGONIST TREATMENT

Ophthalmic Pharmaceutical Compositions

HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON

Liquid Tasimelteon Formulations and Methods of Use Thereof

Liquid Tasimelteon Formulations and Methods of Use Thereof

HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON

ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISO...

MELATONIN AGONIST TREATMENT

HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON

HIGHLY PURIFID PHARMACEUTICAL GRADE TASIMELTEON

MELATONIN AGONIST TREATMENT

METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...

HIGHLY PURIFID PHARMACEUTICAL GRADE TASIMELTEON

METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...

MELATONIN AGONIST TREATMENT

METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...

METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPR...

MELATONIN AGONIST TREATMENT

ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISO...

USE OF A MELATONIN AGONIST FOR THE TREATMENT OF SLEEP DISORDERS INC...

PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALKANOL COMPOUNDS

TREATMENT FOR DEPRESSIVE DISORDERS

MELATONIN AGONIST TREATMENT

STABLE DOSAGE FORMULATIONS OF IMIDAZOLYLALKYL-PYRIDINES